Covid-19 vaccine: Serum’s Adar Poonawalla says SII ready with stockpile of 40-50 million Covishield doses!

Health Tips


COVID-19 Coronavirus Vaccine covishield Serum Institute of India SII Adar PoonawallaCOVID-19 Coronavirus Vaccine: As per the production targets, Adar Poonawalla said SII will be producing around 300 million doses of Covishield by July 2021.  (Reuters image/ Representational Photo)Covid-19 vaccination drive: Adar Poonawalla, chief executive officer of vaccine-maker Serum Institute of India (SII), said on Monday that his firm was ready with a stockpile of about ’40-50 million doses’ of Covid-19 vaccine Covishield.

Poonawalla was quoted by ANI as saying that after Serum International receives regulatory approvals “in a few days”, it will be down to the government to decide how much they can take and how fast.

As far as the production targets are concerned, Adar Poonawalla said SII will be producing around 300 million doses of Covishield by July 2021.

Regarding the availability, or the lack of it, of the Covishield Covid-19 vaccine, he stated that the first six months of 2021 will see a shortage globally. “Nobody can help that. But we will see easing off by August-September 2021 as other vaccine manufactures also being able to supply,” he further added.

More details awaited.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.





Source link